On Tuesday, the Biden administration announced the first 10 medications it will require pharmaceutical companies to negotiate prices on, as part of a provision passed in the Inflation Reduction Act (IRA) last year to lower drug costs, particularly for seniors. Of the 10 drugs listed, four are for diabetes, while the remainder are for treating heart failure, psoriasis and arthritis, blood cancer…
BROADCASTING FOR INDEPENDENCE
